Knee arthroplasty
Drug research and approvals for knee arthroplasty: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 292 studies of knee arthroplasty are recruiting on ClinicalTrials.gov, and Health Canada has authorized 13 drug trials for it since 2013.
- Recruiting worldwide: 292
- Trials authorized in Canada: 13
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 292 recruiting on ClinicalTrials.gov ↗- Tau Pathology in the Brain After Hip or Knee Replacement SurgeryNCT07871487 · Not reported · Uppsala University Hospital · starts Apr 1, 2029
- Electrical Muscle Stimulation (EMS) Versus Standard Physiotherapy for Quadriceps Recovery Following Total Knee…NCT07932821 · Not applicable · MSK Doctors & Associates Ltd · starts Dec 1, 2026
- A Phase 2b Study to Evaluate the Efficacy, Safety, and PK Profiles of TNP-2092 Administered Via IA Injection in PJI…NCT07858916 · Phase 2 · TenNor Therapeutics (Zhongshan) Limited · starts Oct 21, 2026
- Ultrasound Guided Combined Adductor Canal, Superior Genicular Nerves and Anterior Femoral Cutaneous Nerves Blocks in…NCT07705230 · Not applicable · SAMEH ELSHERBINI · starts Oct 20, 2026
- The restor3d Outcomes RegistryNCT07563803 · Not reported · Restor3D · starts Oct 15, 2026
- Suzetrigine in TKANCT07864896 · Phase 3 · Hospital for Special Surgery, New York · starts Oct 15, 2026
- Postoperative Delirium and Analgesia in Elderly PatientsNCT07849517 · Not applicable · Ankara City Hospital Bilkent · starts Oct 1, 2026
- Knee Replacement Rehabilitation Care PathwaysNCT07598539 · Not applicable · University of Pittsburgh · starts Oct 1, 2026
- Preoperative Music Intervention for Anxiety in Hip and Knee ArthroplastyNCT07845695 · Not applicable · Columbia University · starts Sep 22, 2026
- Feasibility of an Early Home-based Cycling Intervention After Knee ArthroplastyNCT07838012 · Not applicable · Central Jutland Regional Hospital · starts Sep 21, 2026
Trials Authorized in Canada
The 10 newest of 13; search them all in Canada trials| Dec 19, 2025 | A phase 3, multicenter, double-blinded, randomized study to evaluate regn7508, a factor xi monoclonal antibody, versus acetylsalicylic acid for prophylaxis of…REGN7508 / ACETYLSALICYLIC ACID | Regeneron | Pending |
| May 7, 2024 | The impact of additional post-operative doses of tranexamic acid on pain, mobility and bleeding following total hip and total knee arthroplasty: a randomized…TRANEXAMIC ACID | ST MARY¿S RESEARCH CENTRE | Ongoing |
| Feb 10, 2023 | Randomized, controlled trial comparing the effectiveness of sedation-epidural anesthesia to spinal anasthesia in outpatient hip or knee arthroplastyCHLOROPROCAINE | CIUSSS DE L'EST DE L'ILE-DE-MONTRÉAL | Closed |
| Dec 2, 2022 | A phase 2, multicenter, randomized, open-label, active-control study of regn9933, a factor xi monoclonal antibody, for prevention of venous thromboembolism…REGN9933 | Regeneron | Ongoing |
| Jun 21, 2022 | Topical vancomycin for infection prophylaxis in total hip and knee arthroplastyVANCOMYCIN | GOVERNORS OF THE UNIVERSITY OF CALGARY | Pending |
| May 11, 2022 | A phase 2b, randomized, double blind, placebo and active comparator, multicenter, safety, and efficacy trial of atx 101 in subjects undergoing total knee…BUPIVACAINE (ATX-101) / CELECOXIB | ALLAY THERAPEUTICS, INC | Closed |
| Nov 22, 2019 | Protocol title: extended venous thromboembolism prophylaxis comparing rivaroxaban and aspirin to aspirin following total hip and knee arthroplasty epcat iiiACETYLSALICYLIC ACID | DR SUDEEP SHIVAKUMAR | Ongoing |
| Apr 9, 2019 | Opioid sparing analgesic strategies for enhanced recovery after total knee arthroplastyKETAMINE | DR VINCENT CHAN | Ongoing |
| Aug 8, 2017 | A randomized, double-blind, double-dummy, multicenter, adaptive design, dose-escalation (part 1) and dose-response (part 2) study to evaluate the safety and…JNJ-64179375 / APIXABAN | Johnson & Johnson | Ongoing |
| Nov 26, 2015 | A phase 3, multi-center, long-term observational study of subjects from tanezumab studies who undergo a total knee, hip, or shoulder replacementPF-04383119 (TANEZUMAB) | Pfizer | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA